Valuation: Steris PLC

Market Cap 24.17B 21.54B 19.75B 17.95B 33.75B 2,284B 34.52B 236B 94.64B 1,209B 90.73B 88.79B 3,830B P/E 2027 *
27.4x
P/E 2028 * 24.4x
Enterprise Value 25.56B 22.78B 20.89B 18.99B 35.69B 2,416B 36.51B 250B 100B 1,279B 95.96B 93.91B 4,051B EV / Sales 2027 *
4.01x
EV / Sales 2028 * 3.69x
Free-Float
99.7%
Yield 2027 *
1.07%
Yield 2028 * 1.16%
Manager TitleAgeSince
Chief Executive Officer 53 2021-07-28
Director of Finance/CFO 59 2025-08-17
Compliance Officer - 2019-07-31
Director TitleAgeSince
Director/Board Member 73 2005-02-28
Director/Board Member 54 2018-04-30
Chairman 67 2018-07-27
Change 5-day change 1-year change 3-year change Capi.($)
+0.96%+3.19% - - 24.17B
-1.75%+8.47%-8.92%+19.40% 200B
-0.84%+6.94%+14.87%+41.44% 128B
-0.88%+7.49%-6.31%+21.04% 129B
+1.51%+7.72%-39.31%+11.17% 97.53B
-2.81%+4.94%-2.02%+76.18% 67.55B
+0.20%+6.22%+19.44%-18.69% 56.98B
-3.71%+16.60%-6.75%+58.76% 55.04B
-1.39%-8.86%-4.24%+57.30% 51.24B
-0.63%+7.01%+5.08%-5.70% 37.43B
Average -0.93%+8.84%-3.13%+28.99% 91.49B
Weighted average by Cap. -1.02%+9.79%-4.80%+27.99%

Financials

2027 *2028 *
Net sales 6.38B 5.68B 5.21B 4.74B 8.91B 603B 9.11B 62.31B 24.98B 319B 23.94B 23.43B 1,011B 6.81B 6.07B 5.56B 5.06B 9.5B 643B 9.72B 66.5B 26.66B 341B 25.55B 25.01B 1,079B
Net income 889M 792M 726M 660M 1.24B 84.01B 1.27B 8.68B 3.48B 44.46B 3.34B 3.27B 141B 990M 882M 809M 735M 1.38B 93.53B 1.41B 9.67B 3.87B 49.5B 3.71B 3.64B 157B
Net Debt 1.39B 1.24B 1.14B 1.04B 1.95B 132B 1.99B 13.61B 5.46B 69.71B 5.23B 5.12B 221B 960M 856M 785M 713M 1.34B 90.74B 1.37B 9.38B 3.76B 48.02B 3.6B 3.53B 152B
Logo Steris PLC
STERIS plc is one of the world's leading suppliers of sterilisation solutions and medical equipment. Net sales by business area break down as follows: - sale of sterilisation solutions and surgical equipment (70.9%): primarily cleaning products, accessories for gastrointestinal surgery, washers, sterilisers, surgical tables, lighting systems, etc. In addition, the group offers equipment repair and maintenance services; - development of sterilisation solutions (19.2%): sterilisation services, laboratory testing, and product and packaging testing for manufacturers of medical devices and pharmaceutical products; - sales of consumables and equipment (9.9%): for biopharmaceutical companies and manufacturers of medical devices. Net sales by source of income break down into sales of equipment (51.5%) and services (48.5%). Net sales are distributed geographically as follows: Ireland (1.8%), the United States (73%) and other (25.2%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Steris PLC